Product
AZD6912
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Phase I, Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2025-06-27